Blockchain Registration Transaction Record

NRx Pharmaceuticals Secures $7.8 Million Funding for Psychiatry Clinic Expansion

NRx Pharmaceuticals announces $7.8 million funding from Universal Capital, LLC to support expansion of interventional psychiatry clinics. HOPE Therapeutics to acquire Dura Medical, Kadima, and NeuroSpa for neuroplastic treatments targeting severe depression and PTSD.

This news matters as it highlights NRx Pharmaceuticals' efforts to provide advanced treatments for mental health conditions like severe depression and PTSD. The funding secured will enable the company to acquire key clinics and expand its innovative therapies, ultimately benefiting patients in need of effective solutions for these debilitating disorders.